Michael Walsh

ORCID: 0000-0001-8292-2014
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Vasculitis and related conditions
  • Dialysis and Renal Disease Management
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Health Systems, Economic Evaluations, Quality of Life
  • Cardiac, Anesthesia and Surgical Outcomes
  • Renal Diseases and Glomerulopathies
  • Otitis Media and Relapsing Polychondritis
  • Chronic Kidney Disease and Diabetes
  • Hemodynamic Monitoring and Therapy
  • Acute Kidney Injury Research
  • Meta-analysis and systematic reviews
  • Blood Pressure and Hypertension Studies
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Central Venous Catheters and Hemodialysis
  • Sarcoidosis and Beryllium Toxicity Research
  • Atrial Fibrillation Management and Outcomes
  • Aortic aneurysm repair treatments
  • Statistical Methods in Clinical Trials
  • Renal and Vascular Pathologies
  • Systemic Lupus Erythematosus Research
  • Diabetes Treatment and Management
  • Heart Failure Treatment and Management
  • Potassium and Related Disorders
  • Hormonal Regulation and Hypertension
  • Pharmacological Effects and Toxicity Studies

McMaster University
2016-2025

Population Health Research Institute
2016-2025

Impact
2017-2025

Hamilton Health Sciences
2016-2025

United States Census Bureau
2025

St. Joseph’s Healthcare Hamilton
2015-2024

Department of Health Research
2024

National Kidney Foundation
2023

ChemoCentryx (United States)
2023

Sullivan Nicolaides Pathology
2023

Cyclophosphamide induction regimens for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis are effective in 70 to 90% of patients, but they associated with high rates death and adverse events. Treatment rituximab has led remission 80 among patients refractory ANCA-associated may be safer than cyclophosphamide regimens.We compared as therapy vasculitis. We randomly assigned, a 3:1 ratio, 44 newly diagnosed renal involvement standard glucocorticoid regimen plus either at dose 375...

10.1056/nejmoa0909169 article EN New England Journal of Medicine 2010-07-14

Abstract Background: Intraoperative hypotension may contribute to postoperative acute kidney injury (AKI) and myocardial injury, but what blood pressures are unsafe is unclear. The authors evaluated the association between intraoperative mean arterial pressure (MAP) risk of AKI injury. Methods: obtained perioperative data for 33,330 noncardiac surgeries at Cleveland Clinic, Ohio. MAP from less than 55 75 mmHg determine threshold where increased. then duration below this their outcomes...

10.1097/aln.0b013e3182a10e26 article EN Anesthesiology 2013-07-04

Accurate information regarding prognosis is fundamental to optimal clinical care. The best approach assess patient relies on prediction models that simultaneously consider a number of prognostic factors and provide an estimate patients' absolute risk event. Such should be characterized by adequately discriminating between patients who will have event those not adequate calibration ensuring accurate risk. This Users' Guide help clinicians understand the available metrics for assessing...

10.1001/jama.2017.12126 article EN JAMA 2017-10-10
Fernando Botto Pablo Alonso‐Coello Matthew T.V. Chan Juan Carlos Villar Denis Xavier and 95 more Sadeesh Srinathan Gordon Guyatt Patrícia Cruz Michelle M. Graham C. Y. Wang Otávio Berwanger Rupert M Pearse Bruce Biccard Valsa Abraham Germán Málaga Graham S. Hillis Reitze Rodseth Deborah J. Cook Carísi Anne Polanczyk Wojciech Szczeklik Daniel I. Sessler Tej Sheth Gareth L. Ackland M. Leuwer Amit X. Garg Yannick LeManach Shirley Pettit Diane Heels‐Ansdell Giovanna Lurati Buse Michael Walsh Robert J. Sapsford Holger J. Schünemann Andrea Kurz Sabu Thomas Marko Mrkobrada Lehana Thabane Hertzel C. Gerstein Pilar Paniagua Peter Nägele Parminder Raina Salim Yusuf P.J. Devereaux Matthew J McQueen Mohit Bhandari Jackie Bosch Norman Buckley Clara K Chow Richard Halliwell Stephen Li Vincent Lee John Mooney Mariana V Furtado Érica Aranha Suzumura Eliana Vieira Santucci Kátia Ramos Moreira Leite Jose Amalth do Espirirto Santo Cesar A P Jardim Alexandre Biasi Cavalcanti Hélio Penna Guimarães Michael J. Jacka Finlay A. McAlister Sean McMurtry Derek R. Townsend Neesh Pannu Sean M. Bagshaw Amal Bessissow Emmanuelle Duceppe John W. Eikelboom Javier Gáname James Hankinson Stephen Hill Sanjit S. Jolly André Lamy Elizabeth Ling Patrick Magloire Guillaume Paré Deven Reddy David Szalay Jacques G. Tittley Jeff Weitz Richard P. Whitlock Saeed Darvish-Kazim Justin DeBeer Peter A. Kavsak Clive Kearon Richard Mizera Martin O’Donnell Matthew McQueen Jehonathan H. Pinthus Sebastián Ribas Marko Šimunović Vikas Tandon Tomas Vanhelder Mitchell Winemaker Sarah McDonald Paul M. O'Bryne Ameen Patel James Paul Zubin Punthakee Karen Raymer

Abstract Background: Myocardial injury after noncardiac surgery (MINS) was defined as prognostically relevant myocardial due to ischemia that occurs during or within 30 days surgery. The study’s four objectives were determine the diagnostic criteria, characteristics, predictors, and 30-day outcomes of MINS. Methods: In this international, prospective cohort study 15,065 patients aged 45 yr older who underwent in-patient surgery, troponin T measured first 3 postoperative days. Patients with a...

10.1097/aln.0000000000000113 article EN Anesthesiology 2014-02-19

The aim of the present study was to detect circulating tumor cells (CTCs) in peripheral blood patients with non-metastatic colon cancer and evaluate whether there is a diurnal variation CTC counts. Furthermore, aimed examine correlation between CTCs TNM stage, other paraclinical variables prognosis.Blood samples were collected from 20 consecutive stage I-III at four different perioperative time points. Detection performed using immunological assay CellSearch®.CTCs detected 1 out 60...

10.1136/ard.2010.137778 article EN Annals of the Rheumatic Diseases 2010-11-24

Little is known about the relationship between perioperative high-sensitivity troponin T (hsTnT) measurements and 30-day mortality myocardial injury after noncardiac surgery (MINS).To determine association hsTnT potential diagnostic criteria for MINS (ie, due to ischemia associated with mortality).Prospective cohort study of patients aged 45 years or older who underwent inpatient had a postoperative measurement. Starting in October 2008, participants were recruited at 23 centers 13...

10.1001/jama.2017.4360 article EN JAMA 2017-04-25

DIALYSISandmedicaltherapies,patients with end-stage renal disease (ESRD) have annual mortality rates exceeding 15%. 1 Cardiovascular disease, manifesting frequently as heart failure or sudden death, is responsible for the majority of deaths. This may be due toahighburdenofexposuretotraditional cardiovascular risk factors (before and after initiation dialysis), well ongoing exposure to volume overload, hyperphosphatemia,chronicinflammation,and other uremia-related factors.Taken together,...

10.1001/jama.298.11.1291 article EN JAMA 2007-09-18

<h3>Context</h3>Current remission maintenance therapies for antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) are limited by partial efficacy and toxicity.<h3>Objective</h3>To compare the effects of mycophenolate mofetil with azathioprine on prevention relapses in patients AAV.<h3>Design, Setting, Participants</h3>Open-label randomized controlled trial, International Mycophenolate Mofetil Protocol to Reduce Outbreaks Vasculitides (IMPROVE), test hypothesis that is more...

10.1001/jama.2010.1658 article EN JAMA 2010-11-09

<h3>BACKGROUND:</h3> Most randomized controlled trials (RCTs) and meta-analyses of RCTs examine effect modification (also called a subgroup or interaction), in which the an intervention varies by another variable (e.g., age disease severity). Assessing credibility apparent presents challenges; therefore, we developed Instrument for assessing Credibility Effect Modification Analyses (ICEMAN). <h3>METHODS:</h3> To develop ICEMAN, established detailed concept; identified candidate...

10.1503/cmaj.200077 article EN cc-by-nc-nd Canadian Medical Association Journal 2020-08-09

<h3>Introduction</h3> The previously reported randomised controlled trial of a consensus regimen pulse cyclophosphamide suggested that it was as effective daily oral (DO) for remission induction antineutrophil cytoplasm autoantibodies-associated systemic vasculitis when both were combined with the same glucocorticoid protocol (CYCLOPS study (Randomised versus Cyclophosphamide therapy ANCA-associated Systemic Vasculitis published de groot K, harper L <i>et al</i> Ann Int Med 2009)). had...

10.1136/annrheumdis-2011-200477 article EN Annals of the Rheumatic Diseases 2011-11-29

Potassium disorders are common in patients with kidney disease, particularly tubular and low glomerular filtration rate. A multidisciplinary group of researchers clinicians met October 2018 to identify evidence address controversies potassium management. The issues discussed encompassed our latest understanding the regulation excretion health disease; relationship intake cardiovascular outcomes, increasing showing beneficial associations plant-based diet data suggest a paradigm shift from...

10.1016/j.kint.2019.09.018 article EN cc-by-nc-nd Kidney International 2019-10-10

To determine the association between characteristics at diagnosis and time to first relapse in a large cohort of patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV).We studied long-term followup data from 4 clinical trials that included newly diagnosed broad spectrum AAV severity manifestations. Patient disease baseline were used competing risk regression models as event interest death event.We assessed 535 1,804 patient-years relapse. At diagnosis, median age was...

10.1002/art.33361 article EN Arthritis & Rheumatism 2011-09-28

Background Meta-analyses including a limited number of patients and events are prone to yield overestimated intervention effect estimates. While many assume bias is the cause overestimation, theoretical considerations suggest that random error may be an equal or more frequent cause. The independent impact on meta-analyzed effects has not previously been explored. It suggested surpassing optimal information size (i.e., required meta-analysis sample size) provides sufficient protection against...

10.1371/journal.pone.0025491 article EN cc-by PLoS ONE 2011-10-18

Assessment of heterogeneity is essential in systematic reviews and meta-analyses clinical trials. The most commonly used measure, I(2), provides an estimate the proportion variability a meta-analysis that explained by differences between included trials rather than sampling error. Recent studies have raised concerns about reliability I(2) estimates, due to their dependence on precision time-dependent biases. Authors also advocated use 95% confidence intervals (CIs) express uncertainty...

10.1371/journal.pone.0039471 article EN cc-by PLoS ONE 2012-07-25

Objectives The RITUXVAS trial reported similar remission induction rates and safety between rituximab cyclophosphamide based regimens for antineutrophil cytoplasm antibody (ANCA)-associated vasculitis at 12 months; however, immunosuppression maintenance requirements longer-term outcomes after in ANCA-associated renal are unknown. Methods Forty-four patients with newly diagnosed involvement were randomised, 3:1, to glucocorticoids plus either (375 mg/m 2 /week×4) two intravenous pulses (n=33,...

10.1136/annrheumdis-2014-206404 article EN Annals of the Rheumatic Diseases 2015-03-04

Granulomatosis with polyangiitis (GPA, Wegener's) and microscopic (MPA) are small vessel vasculitides collectively referred to as anti-neutrophil cytoplasm antibody-associated vasculitis (AAV). AAV is associated high rates of morbidity mortality due uncontrolled disease treatment toxicity. Small randomized trials suggest adjunctive plasma exchange may improve control, while observational evidence suggests that current oral glucocorticoid doses severe infections in patients AAV. A study both...

10.1186/1745-6215-14-73 article EN cc-by Trials 2013-01-01

Cyclophosphamide induction regimens are effective for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), but associated with infections, malignancies and infertility. Mycophenolate mofetil (MMF) has shown high remission rates in small studies of AAV.We conducted a randomised controlled trial to investigate whether MMF was non-inferior cyclophosphamide AAV. 140 newly diagnosed patients were randomly assigned or pulsed cyclophosphamide. All received the same oral...

10.1136/annrheumdis-2018-214245 article EN Annals of the Rheumatic Diseases 2019-01-05

Bullous pemphigoid is a blistering skin disorder with increased mortality. We tested whether strategy of starting treatment doxycycline gives acceptable short-term blister control while conferring long-term safety advantages over oral corticosteroids.We did pragmatic, multicentre, parallel-group randomised controlled trial adults bullous (three or more blisters at two sites and linear basement membrane IgG C3). Participants were randomly assigned to (200 mg per day) prednisolone (0·5 mg/kg...

10.1016/s0140-6736(17)30560-3 article EN cc-by The Lancet 2017-03-07
Allison Tong Braden Manns Brenda R. Hemmelgarn David C. Wheeler Nicole Evangelidis and 95 more Peter Tugwell Sally Crowe Wim Van Biesen Wolfgang C. Winkelmayer­ Dónal O’Donoghue Helen Tam‐Tham Jenny I. Shen J Pintér Nicholas Larkins Sajeda Youssouf Sreedhar Mandayam Angela Ju Jonathan C. Craig Allan Collins Andrew S. Narva Bénédicte Sautenet Billy J. Powell Brenda Hurd Brendan J. Barrett Brigitte Schiller Bruce F. Culleton Carmel M. Hawley Carol A. Pollock Charmaine E. Lok Christoph Wanner Christopher T. Chan Daniel Weiner David Harris David W. Johnson David Rosenbloom Dena E. Rifkin Deshia Bookman Edwina A. Brown Elena Bavlovlenkov Francesca Tentori Jack M. Williams Jane O. Schell Jennifer E. Flythe Joachim H. Ix Jochen G. Raimann Joel Andress John Agar John T. Daugirdas John Gill John W. Kusek Kevan R. Polkinghorne Kevin C. Abbott Len Usyvat Mahesh Krishnan Marcello Tonelli Mark R. Marshall Martin Gallagher Michael J. Germain Michael Walsh Michael Zappitelli Michelle A. Josephson Nilka Rı́os Burrows Orlando Houston Peter G. Kerr Peter Kotanko Prabir Roy‐Chaudhury Rachael L. Morton R. M. L. Mehrotra René van den Dorpel Rita S. Suri Ron Wald Ronke Apata Shalia Gibson Sharrilyn Evered Stephen Z. Fadem S. McDonald S. Holt Terence Kee Braden Manns Brenda R. Hemmelgarn David C. Wheeler Tess Harris Wolfgang C. Winkelmayer­ Allison Tong Andrew S. Narva Billy J. Powell Brenda Hurd Brendan J. Barrett Brigitte Schiller Bruce F. Culleton Carmel M. Hawley Charmaine E. Lok Christoph Wanner Daniel Weiner David W. Johnson David Rosenbloom Dena E. Rifkin Deshia Bookman Dónal O’Donoghue Edwina A. Brown

10.1053/j.ajkd.2016.05.022 article EN American Journal of Kidney Diseases 2016-08-04
Frank B. Cortazar John L. Niles David Jayne Peter A. Merkel Annette Bruchfeld and 95 more Huibin Yue Thomas J. Schall Pirow Bekker Chen Au Peh Aron Chakera Bruce A. Cooper Jadadeesh Kurtkoti Daman Langguth Vicki Levidiotis G. Luxton Peter F. Mount David W. Mudge Euan Noble R. Phoon Dwarakanathan Ranganathan A. Ritchie Jessica Ryan M. Suranyi Alexander R. Rosenkranz K. Lhotta Andreas Kronbichler Nathalie Demoulin C. Bovy R. Hellemans Jean‐Michel Hougardy Ben Sprangers Katherine D. Wissing Christian Pagnoux S. Barbour Soumeya Brachemi S. Cournoyer Louis Girard Louis‐Philippe Laurin Patrick Liang David Philibert Michael Walsh Vladimı́r Tesař Radim Bečvář P. Horak Ivan Rychlík Wladimir Szpirt Hans Dieperink Jon Waarst Gregersen Per Ivarsen Elizabeth Krarup Cecilie Lyngsoe Claire Rigothier Jean‐François Augusto Alexandre Bélot Dominique Chauveau Divi Cornec Noémie Jourde‐Chiche M. Ficheux Alexandre Karras Armelle Klein F. Maurier Rafik Mesbah Olivier Moranne A. Néel T. Quéméneur David Saadoun Benjamin Terrier Philippe Zaoui Matthias Schaier Urs Benck Raoul Bergner Matthias H. Busch Jürgen Floege Franziska Grundmann Hermann Haller Marion Haubitz B. Hellmich Jörg Henes Bernd Hohenstein C. Hugo Christof Iking‐Konert Fabian Arndt Torsten Kubacki Ina Kötter Peter Lamprecht Tom H. Lindner Jan Halbritter H. Mehling Ulf Schönermarck Nils Venhoff Volker Vielhauer Oliver Witzke István Szombati G Szücs Giacomo Garibotto Federico Alberici Enrico Brunetta Lorenzo Dagna Salvatore De Vita Giacomo Emmi

In the 330-patient ADVOCATE trial of avacopan for treatment antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis, in which 81% patients had renal involvement, estimated glomerular filtration rate (eGFR) increased on average 7.3 ml/min per 1.73 m2 group and 4.1 prednisone (P = 0.029) at week 52. This new analysis examines results patient subgroup with severe insufficiency enrollment into trial, i.e., eGFR ≤20 m2.eGFR was determined baseline over course trial. Changes were...

10.1016/j.ekir.2023.01.039 article EN cc-by-nc-nd Kidney International Reports 2023-02-03
Coming Soon ...